Covid-19 Impact on Pneumococcal Vaccines Market , Global Research Reports 2020-2021

1.2 Market Segmentation

1.3 Research Objectives

1.4 Research Methodology

1.4.1 Research Process

1.4.2 Data Triangulation

1.4.3 Research Approach

1.4.4 Base Year

1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth

1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections

1.5.2 Covid-19 Impact: Commodity Prices Indices

1.5.3 Covid-19 Impact: Global Major Government Policy

1.6 The Covid-19 Impact on Pneumococcal Vaccines Industry

1.7 COVID-19 Impact: Pneumococcal Vaccines Market Trends

2 Global Pneumococcal Vaccines Quarterly Market Size Analysis

2.1 Pneumococcal Vaccines Business Impact Assessment - COVID-19

2.1.1 Global Pneumococcal Vaccines Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026

2.1.2 Global Pneumococcal Vaccines Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026

2.2 Global Pneumococcal Vaccines Quarterly Market Size 2020-2021

2.3 COVID-19-Driven Market Dynamics and Factor Analysis

2.3.1 Drivers

2.3.2 Restraints

2.3.3 Opportunities

2.3.4 Challenges

3 Quarterly Competitive Assessment, 2020

3.1 Global Pneumococcal Vaccines Quarterly Market Size by Manufacturers, 2019 VS 2020

3.2 Global Pneumococcal Vaccines Factory Price by Manufacturers

3.3 Location of Key Manufacturers Pneumococcal Vaccines Manufacturing Factories and Area Served

3.4 Date of Key Manufacturers Enter into Pneumococcal Vaccines Market

3.5 Key Manufacturers Pneumococcal Vaccines Product Offered

3.6 Mergers & Acquisitions, Expansion Plans

4 Impact of Covid-19 on Pneumococcal Vaccines Segments, By Type

4.1 Introduction

1.4.1 PPSV 23

1.4.2 PCV 7/13

1.4.3 PCV 10

4.2 By Type, Global Pneumococcal Vaccines Market Size, 2019-2021

4.2.1 By Type, Global Pneumococcal Vaccines Market Size by Type, 2020-2021

4.2.2 By Type, Global Pneumococcal Vaccines Price, 2020-2021

5 Impact of Covid-19 on Pneumococcal Vaccines Segments, By Application

5.1 Overview

5.5.1 For Infants

5.5.2 For Children (2-10)

5.5.3 For Person (10-64)

5.5.4 For The Old (Above 65)

5.2 By Application, Global Pneumococcal Vaccines Market Size, 2019-2021

5.2.1 By Application, Global Pneumococcal Vaccines Market Size by Application, 2019-2021

5.2.2 By Application, Global Pneumococcal Vaccines Price, 2020-2021

6 Geographic Analysis

6.1 Introduction

6.2 North America

6.2.1 Macroeconomic Indicators of US

6.2.2 US

6.2.3 Canada

6.3 Europe

6.3.1 Macroeconomic Indicators of Europe

6.3.2 Germany

6.3.3 France

6.3.4 UK

6.3.5 Italy

6.4 Asia-Pacific

6.4.1 Macroeconomic Indicators of Asia-Pacific

6.4.2 China

6.4.3 Japan

6.4.4 South Korea

6.4.5 India

6.4.6 ASEAN

6.5 Rest of World

6.5.1 Latin America

6.5.2 Middle East and Africa

7 Company Profiles

7.1 Pfizer

7.1.1 Pfizer Business Overview

7.1.2 Pfizer Pneumococcal Vaccines Quarterly Production and Revenue, 2020

7.1.3 Pfizer Pneumococcal Vaccines Product Introduction

7.1.4 Pfizer Response to COVID-19 and Related Developments

7.2 Sanofi

7.2.1 Sanofi Business Overview

7.2.2 Sanofi Pneumococcal Vaccines Quarterly Production and Revenue, 2020

7.2.3 Sanofi Pneumococcal Vaccines Product Introduction

7.2.4 Sanofi Response to COVID-19 and Related Developments

7.3 GSK

7.3.1 GSK Business Overview

7.3.2 GSK Pneumococcal Vaccines Quarterly Production and Revenue, 2020

7.3.3 GSK Pneumococcal Vaccines Product Introduction

7.3.4 GSK Response to COVID-19 and Related Developments

7.4 Merck

7.4.1 Merck Business Overview

7.4.2 Merck Pneumococcal Vaccines Quarterly Production and Revenue, 2020

7.4.3 Merck Pneumococcal Vaccines Product Introduction

7.4.4 Merck Response to COVID-19 and Related Developments

7.5 Eli Lilly

7.5.1 Eli Lilly Business Overview

7.5.2 Eli Lilly Pneumococcal Vaccines Quarterly Production and Revenue, 2020

7.5.3 Eli Lilly Pneumococcal Vaccines Product Introduction

7.5.4 Eli Lilly Response to COVID-19 and Related Developments

7.6 AstraZeneca

7.6.1 AstraZeneca Business Overview

7.6.2 AstraZeneca Pneumococcal Vaccines Quarterly Production and Revenue, 2020

7.6.3 AstraZeneca Pneumococcal Vaccines Product Introduction

7.6.4 AstraZeneca Response to COVID-19 and Related Developments

7.7 Abera

7.7.1 Abera Business Overview

7.7.2 Abera Pneumococcal Vaccines Quarterly Production and Revenue, 2020

7.7.3 Abera Pneumococcal Vaccines Product Introduction

7.7.4 Abera Response to COVID-19 and Related Developments

7.8 S K Chemicals

7.8.1 S K Chemicals Business Overview

7.8.2 S K Chemicals Pneumococcal Vaccines Quarterly Production and Revenue, 2020

7.8.3 S K Chemicals Pneumococcal Vaccines Product Introduction

7.8.4 S K Chemicals Response to COVID-19 and Related Developments

7.9 Beijing Minhai Biotechnology

7.9.1 Beijing Minhai Biotechnology Business Overview

7.9.2 Beijing Minhai Biotechnology Pneumococcal Vaccines Quarterly Production and Revenue, 2020

7.9.3 Beijing Minhai Biotechnology Pneumococcal Vaccines Product Introduction

7.9.4 Beijing Minhai Biotechnology Response to COVID-19 and Related Developments

7.10 Baxter

7.10.1 Baxter Business Overview

7.10.2 Baxter Pneumococcal Vaccines Quarterly Production and Revenue, 2020

7.10.3 Baxter Pneumococcal Vaccines Product Introduction

7.10.4 Baxter Response to COVID-19 and Related Developments

7.11 Biken

7.11.1 Biken Business Overview

7.11.2 Biken Pneumococcal Vaccines Quarterly Production and Revenue, 2020

7.11.3 Biken Pneumococcal Vaccines Product Introduction

7.11.4 Biken Response to COVID-19 and Related Developments

7.12 Celgene Corporation

7.12.1 Celgene Corporation Business Overview

7.12.2 Celgene Corporation Pneumococcal Vaccines Quarterly Production and Revenue, 2020

7.12.3 Celgene Corporation Pneumococcal Vaccines Product Introduction

7.12.4 Celgene Corporation Response to COVID-19 and Related Developments

7.13 Panacea Biotec

7.13.1 Panacea Biotec Business Overview

7.13.2 Panacea Biotec Pneumococcal Vaccines Quarterly Production and Revenue, 2020

7.13.3 Panacea Biotec Pneumococcal Vaccines Product Introduction

7.13.4 Panacea Biotec Response to COVID-19 and Related Developments

7.14 Serum Institute of India

7.14.1 Serum Institute of India Business Overview

7.14.2 Serum Institute of India Pneumococcal Vaccines Quarterly Production and Revenue, 2020

7.14.3 Serum Institute of India Pneumococcal Vaccines Product Introduction

7.14.4 Serum Institute of India Response to COVID-19 and Related Developments

7.15 Genentech

7.15.1 Genentech Business Overview

7.15.2 Genentech Pneumococcal Vaccines Quarterly Production and Revenue, 2020

7.15.3 Genentech Pneumococcal Vaccines Product Introduction

7.15.4 Genentech Response to COVID-19 and Related Developments

7.16 Genocea Biosciences

7.16.1 Genocea Biosciences Business Overview

7.16.2 Genocea Biosciences Pneumococcal Vaccines Quarterly Production and Revenue, 2020

7.16.3 Genocea Biosciences Pneumococcal Vaccines Product Introduction

7.16.4 Genocea Biosciences Response to COVID-19 and Related Developments

7.17 ImmunoBiology

7.17.1 ImmunoBiology Business Overview

7.17.2 ImmunoBiology Pneumococcal Vaccines Quarterly Production and Revenue, 2020

7.17.3 ImmunoBiology Pneumococcal Vaccines Product Introduction

7.17.4 ImmunoBiology Response to COVID-19 and Related Developments

7.18 Lupin

7.18.1 Lupin Business Overview

7.18.2 Lupin Pneumococcal Vaccines Quarterly Production and Revenue, 2020

7.18.3 Lupin Pneumococcal Vaccines Product Introduction

7.18.4 Lupin Response to COVID-19 and Related Developments

7.19 Nuron Biotech

7.19.1 Nuron Biotech Business Overview

7.19.2 Nuron Biotech Pneumococcal Vaccines Quarterly Production and Revenue, 2020

7.19.3 Nuron Biotech Pneumococcal Vaccines Product Introduction

7.19.4 Nuron Biotech Response to COVID-19 and Related Developments

7.20 Biogen

7.20.1 Biogen Business Overview

7.20.2 Biogen Pneumococcal Vaccines Quarterly Production and Revenue, 2020

7.20.3 Biogen Pneumococcal Vaccines Product Introduction

7.20.4 Biogen Response to COVID-19 and Related Developments

7.21 Valneva Austria

7.21.1 Valneva Austria Business Overview

7.21.2 Valneva Austria Pneumococcal Vaccines Quarterly Production and Revenue, 2020

7.21.3 Valneva Austria Pneumococcal Vaccines Product Introduction

7.21.4 Valneva Austria Response to COVID-19 and Related Developments

7.22 Sinovac

7.22.1 Sinovac Business Overview

7.22.2 Sinovac Pneumococcal Vaccines Quarterly Production and Revenue, 2020

7.22.3 Sinovac Pneumococcal Vaccines Product Introduction

7.22.4 Sinovac Response to COVID-19 and Related Developments

8 Supply Chain and Sales Channels Analysis

8.1 Pneumococcal Vaccines Supply Chain Analysis

8.1.1 Pneumococcal Vaccines Supply Chain Analysis

8.1.2 Covid-19 Impact on Pneumococcal Vaccines Supply Chain

8.2 Distribution Channels Analysis

8.2.1 Pneumococcal Vaccines Distribution Channels

8.2.2 Covid-19 Impact on Pneumococcal Vaccines Distribution Channels

8.2.3 Pneumococcal Vaccines Distributors

8.3 Pneumococcal Vaccines Customers

9 Key Findings

10 Appendix

10.1 About Us

10.2 Disclaimer

Table 1. Overview of the World Economic Outlook Projections

Table 2. Summary of World Real per Capita Output (Annual percent change; in international currency at purchasing power parity)

Table 3. European Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)

Table 4. Asian and Pacific Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)

Table 5. Western Hemisphere Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)

Table 6. Middle Eastern and Central Asian Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)

Table 7. Covid-19 Impact: Global Major Government Policy

Table 8. The Covid-19 Impact on Pneumococcal Vaccines Assessment

Table 9. COVID-19 Impact: Pneumococcal Vaccines Market Trends

Table 10. COVID-19 Impact Global Pneumococcal Vaccines Market Size

Table 11. Global Pneumococcal Vaccines Market Size Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (K Units)

Table 12. Global Pneumococcal Vaccines Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026, (USD/Unit)

Table 13. Global Pneumococcal Vaccines Quarterly Market Size, 2020 (US$ Million) & (K Units)

Table 14. Global Pneumococcal Vaccines Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (US$ Million)

Table 15. Global Pneumococcal Vaccines Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (K Units)

Table 16. Global Pneumococcal Vaccines Market Growth Drivers

Table 17. Global Pneumococcal Vaccines Market Restraints

Table 18. Global Pneumococcal Vaccines Market Opportunities

Table 19. Global Pneumococcal Vaccines Market Challenges

Table 20. Key Manufacturers Pneumococcal Vaccines Quarterly Revenue, 2019 VS 2020 (US$ Million)

Table 21. Top Manufacturers, Pneumococcal Vaccines Market Size, 2019 (K Units) & (US$ Million)

Table 22. Pneumococcal Vaccines Factory Price by Manufacturers 2020 (USD/Unit)

Table 23. Location of Key Manufacturers Pneumococcal Vaccines Manufacturing Plants

Table 24. Key Manufacturers Pneumococcal Vaccines Market Served

Table 25. Date of Key Manufacturers Enter into Pneumococcal Vaccines Market

Table 26. Key Manufacturers Pneumococcal Vaccines Product Type

Table 27. Mergers & Acquisitions, Expansion Plans

Table 28. Global Pneumococcal Vaccines Market Size by Type, 2020, (US$ Million)

Table 29. Global Pneumococcal Vaccines Market Size by Type, 2020 (K Units)

Table 30. Global Pneumococcal Vaccines Price: by Type, 2020-2021 (USD/Unit)

Table 31. Global Pneumococcal Vaccines Market Size by Application: 2020-2021 (US$ Million)

Table 32. Global Pneumococcal Vaccines Market Size by Application, 2020-2021 (K Units)

Table 33. Global Pneumococcal Vaccines Price: by Application, 2020-2021 (USD/Unit)

Table 34. Global Pneumococcal Vaccines Market Size by Region, 2019-2021 (US$ Million)

Table 35. Global Pneumococcal Vaccines Market Size by Region, 2019-2021 (K Units)

Table 36. By Country, North America Pneumococcal Vaccines Market Size, 2019-2021 (US$ Million)

Table 37. By Country, North America Pneumococcal Vaccines Market Size, 2019-2021 (K Units)

Table 38. US Pneumococcal Vaccines Market Size, 2019-2021 (US$ Million) & (K Units)

Table 39. Canada Pneumococcal Vaccines Market Size, 2019-2021 (US$ Million) & (K Units)

Table 40. Macroeconomic Indicators of Europe (Germany, France, UK and Italy)

Table 41. By Country, Europe Pneumococcal Vaccines Market Size, 2019-2021 (US$ Million)

Table 42. By Country, Europe Pneumococcal Vaccines Market Size, 2019-2021 (K Units)

Table 43. Germany Pneumococcal Vaccines Market Size, 2019-2021 (US$ Million) & (K Units)

Table 44. France Pneumococcal Vaccines Market Size, 2019-2021 (US$ Million) & (K Units)

Table 45. UK Pneumococcal Vaccines Market Size, 2019-2021 (US$ Million) & (K Units)

Table 46. Italy Pneumococcal Vaccines Market Size, 2019-2021 (US$ Million) & (K Units)

Table 47. Macroeconomic Indicators of Asia-Pacific (China, Japan, South Korea, India and ASEAN)

Table 48. By Region, Asia-Pacific Pneumococcal Vaccines Market Size, 2019-2021 (US$ Million)

Table 49. By Region, Asia-Pacific Pneumococcal Vaccines Market Size, 2019-2021 (K Units)

Table 50. China Pneumococcal Vaccines Market Size, 2019-2021 (US$ Million) & (K Units)

Table 51. Japan Pneumococcal Vaccines Market Size, 2019-2021 (US$ Million) & (K Units)

Table 52. South Korea Pneumococcal Vaccines Market Size, 2019-2021 (US$ Million) & (K Units)

Table 53. India Pneumococcal Vaccines Market Size, 2019-2021 (US$ Million) & (K Units)

Table 54. ASEAN Pneumococcal Vaccines Market Size, 2019-2021 (US$ Million) & (K Units)

Table 55. Latin America Pneumococcal Vaccines Market Size, 2019-2021 (US$ Million) & (K Units)

Table 56. Middle East and Africa Pneumococcal Vaccines Market Size, 2019-2021 (US$ Million) & (K Units)

Table 57. Pfizer Business Overview

Table 58. Pfizer Pneumococcal Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 59. Pfizer Pneumococcal Vaccines Product

Table 60. Pfizer Response to COVID-19 and Related Developments

Table 61. Sanofi Business Overview

Table 62. Sanofi Pneumococcal Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 63. Sanofi Pneumococcal Vaccines Product

Table 64. Sanofi Response to COVID-19 and Related Developments

Table 65. GSK Business Overview

Table 66. GSK Pneumococcal Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 67. GSK Pneumococcal Vaccines Product

Table 68. GSK Response to COVID-19 and Related Developments

Table 69. Merck Business Overview

Table 70. Merck Pneumococcal Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 71. Merck Pneumococcal Vaccines Product

Table 72. Merck Response to COVID-19 and Related Developments

Table 73. Eli Lilly Business Overview

Table 74. Eli Lilly Pneumococcal Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 75. Eli Lilly Pneumococcal Vaccines Product

Table 76. Eli Lilly Response to COVID-19 and Related Developments

Table 77. AstraZeneca Business Overview

Table 78. AstraZeneca Pneumococcal Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 79. AstraZeneca Pneumococcal Vaccines Product

Table 80. AstraZeneca Response to COVID-19 and Related Developments

Table 81. Abera Business Overview

Table 82. Abera Pneumococcal Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 83. Abera Pneumococcal Vaccines Product

Table 84. Abera Response to COVID-19 and Related Developments

Table 85. S K Chemicals Business Overview

Table 86. S K Chemicals Pneumococcal Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 87. S K Chemicals Pneumococcal Vaccines Product

Table 88. S K Chemicals Response to COVID-19 and Related Developments

Table 89. Beijing Minhai Biotechnology Business Overview

Table 90. Beijing Minhai Biotechnology Pneumococcal Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 91. Beijing Minhai Biotechnology Pneumococcal Vaccines Product

Table 92. Beijing Minhai Biotechnology Response to COVID-19 and Related Developments

Table 93. Baxter Business Overview

Table 94. Baxter Pneumococcal Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 95. Baxter Pneumococcal Vaccines Product

Table 96. Baxter Response to COVID-19 and Related Developments

Table 97. Biken Business Overview

Table 98. Biken Pneumococcal Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 99. Biken Pneumococcal Vaccines Product

Table 100. Biken Response to COVID-19 and Related Developments

Table 101. Celgene Corporation Business Overview

Table 102. Celgene Corporation Pneumococcal Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 103. Celgene Corporation Pneumococcal Vaccines Product

Table 104. Celgene Corporation Response to COVID-19 and Related Developments

Table 105. Panacea Biotec Business Overview

Table 106. Panacea Biotec Pneumococcal Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 107. Panacea Biotec Pneumococcal Vaccines Product

Table 108. Panacea Biotec Response to COVID-19 and Related Developments

Table 109. Serum Institute of India Business Overview

Table 110. Serum Institute of India Pneumococcal Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 111. Serum Institute of India Pneumococcal Vaccines Product

Table 112. Serum Institute of India Response to COVID-19 and Related Developments

Table 113. Genentech Business Overview

Table 114. Genentech Pneumococcal Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 115. Genentech Pneumococcal Vaccines Product

Table 116. Genentech Response to COVID-19 and Related Developments

Table 117. Genocea Biosciences Business Overview

Table 118. Genocea Biosciences Pneumococcal Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 119. Genocea Biosciences Pneumococcal Vaccines Product

Table 120. Genocea Biosciences Response to COVID-19 and Related Developments

Table 121. ImmunoBiology Business Overview

Table 122. ImmunoBiology Pneumococcal Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 123. ImmunoBiology Pneumococcal Vaccines Product

Table 124. ImmunoBiology Response to COVID-19 and Related Developments

Table 125. Lupin Business Overview

Table 126. Lupin Pneumococcal Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 127. Lupin Pneumococcal Vaccines Product

Table 128. Lupin Response to COVID-19 and Related Developments

Table 129. Nuron Biotech Business Overview

Table 130. Nuron Biotech Pneumococcal Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 131. Nuron Biotech Pneumococcal Vaccines Product

Table 132. Nuron Biotech Response to COVID-19 and Related Developments

Table 133. Biogen Business Overview

Table 134. Biogen Pneumococcal Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 135. Biogen Pneumococcal Vaccines Product

Table 136. Biogen Response to COVID-19 and Related Developments

Table 137. Valneva Austria Business Overview

Table 138. Valneva Austria Pneumococcal Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 139. Valneva Austria Pneumococcal Vaccines Product

Table 140. Valneva Austria Response to COVID-19 and Related Developments

Table 141. Sinovac Business Overview

Table 142. Sinovac Pneumococcal Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 143. Sinovac Pneumococcal Vaccines Product

Table 144. Sinovac Response to COVID-19 and Related Developments

Table 145. Pneumococcal Vaccines Distributors List

Table 146. Pneumococcal Vaccines Customers List

Table 147. Covid-19 Impact on Pneumococcal Vaccines Customers

List of Figures

Figure 1. Pneumococcal Vaccines Product Picture

Figure 2. Pneumococcal Vaccines Market Segmentation

Figure 3. Research Objectives

Figure 4. Research Process

Figure 5. Data Triangulation

Figure 6. Research Approach

Figure 7. Commodity Prices-Metals Price Indices

Figure 8. Commodity Prices- Precious Metal Price Indices

Figure 9. Commodity Prices- Agricultural Raw Material Price Indices

Figure 10. Commodity Prices- Food and Beverage Price Indices

Figure 11. Commodity Prices- Fertilizer Price Indices

Figure 12. Commodity Prices- Energy Price Indices

Figure 13. G20+: Economic Policy Responses to COVID-19

Figure 14. Global Pneumococcal Vaccines Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (US$ Million)

Figure 15. Global Pneumococcal Vaccines Market Size, Pre-COVID-19 and Post- COVID-19, Year-over-Year Growth Rate, 2015-2026 (%)

Figure 16. Global Pneumococcal Vaccines Market Size, Quarterly Growth, 2020-2021 (%)

Figure 17. Global Pneumococcal Vaccines Market Size, Market Share by Type, 2019 VS 2020 (%)

Figure 18. Global Pneumococcal Vaccines Market Size, Market Share by Application, 2019 VS 2020 (%)

Figure 19. Global Pneumococcal Vaccines Market Size Market Share by Region, 2019 VS 2020 (%)

Figure 20. United States Composite PMI and GDP

Figure 21. Eurozone Composite PMI and GDP

Figure 22. Eurozone Core v. Periphery PMI Output Indices

Figure 23. Core v. Periphery PMI Employment Indices

Figure 24. UK Composite PMI and GDP

Figure 25. Caixin China Composite Output Index

Figure 26. Caixin China General Services Business Activity Index

Figure 27. Japan Composite Output Index

Figure 28. South Korea Manufacturing PMI

Figure 29. India Composite Output Index

Figure 30. ASEAN Manufacturing PMI

Figure 31. By Region, Asia-Pacific Pneumococcal Vaccines Market Size Market Share, 2019-2021